• 011-26907444
  • raghava@iiitd.ac.in

Welcome to Peptide Card of AntiTbPdb

This page displays user query in tabular form.

FWGALAKGALKLIPSLFSSFSKKD details
Primary information
ID antitb_1185,
Name25019413
N-Terminal modificationPin2
C-Terminal ModificationFWGALAKGALKLIPSLFSSFSKKD
Chemical ModificationFree
Linear/CyclicFree
LengthNone
ChiralityLinear
Nature24
SourceL
OriginCationic
SpeciesNatural
StrainVenom of the African scorpion Pandinus imperator
Inhibition ConcentrationMycobacterium tuberculosis
In Vitro/ In vivoMycobacterium tuberculosis H37Rv
Cell LineMIC = 57.7 ± 22.3 μg/ml or 22.1 ± 8.6 μM
Inhibition ConcentrationIn vitro
Sequence2014
CytotoxicityRBC
In vivo ModelNA
Lethal DoseHemolysis ( IC-50 = 3.3 [1.9–5.7])
Immune ResponceNone
Mechanism of ActionNA
TargetNA
Combination TherapyCell wall disruption
Other activitiesCell wall
PMIDNone
Year of PublicationAnti-bacterial (E. coli, S. aureus)
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1186,
Name25019413
N-Terminal modificationPin2
C-Terminal ModificationFWGALAKGALKLIPSLFSSFSKKD
Chemical ModificationFree
Linear/CyclicFree
LengthNone
ChiralityLinear
Nature24
SourceL
OriginCationic
SpeciesNatural
StrainVenom of the African scorpion Pandinus imperator
Inhibition ConcentrationMycobacterium tuberculosis
In Vitro/ In vivoMycobacterium tuberculosis muti-drug resistant strain (MDR) clinical isolate
Cell LineMIC = 86.5 μg/ml or 33.1 μM
Inhibition ConcentrationIn vitro
Sequence2014
CytotoxicityRBC
In vivo ModelNA
Lethal DoseHemolysis ( IC-50 = 3.3 [1.9–5.7])
Immune ResponceNone
Mechanism of ActionNA
TargetNA
Combination TherapyCell wall disruption
Other activitiesCell wall
PMIDNone
Year of PublicationAnti-bacterial (E. coli, S. aureus)
Tertiary Structure
(Technique)
Not Predicted),